[Evaluation of lymphocytoxic antibody specificity in systemic lupus erythematosus: correlation with the clinical activity of the disease].
Forty two sera of 35 patients with systemic lupus erythematosus with or without clinically active disease were evaluated. The lymphocytotoxic complement dependent antibodies were detected in 66.66% of patients and were not related to class I of principal histocompatibility antigens or therapeutical use of corticosteroids.